Immunovant Inc. Common Stock vs Welltower Inc. Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.25B), while Welltower Inc. Common Stock trades at $223.12 (market cap $159.33B). The key difference: Welltower Inc. Common Stock is far larger — about 25.5× Immunovant Inc. Common Stock's market cap, and Welltower Inc. Common Stock pays a 1.54% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Welltower Inc. Common Stock for 0 Days on average.
| IMVT | WELL | |
|---|---|---|
Market Cap | $6.25B | $159.33B |
Volume | 1,755,411 | 2,484,986 |
Sector | Health | Real Estate |
52-Week High | $44.96 | $252.07 |
52-Week Low | $17.03 | $165.94 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.35B | $177.09B |
Dividend Yield | — | 1.54% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →Welltower is a real estate investment trust focused on healthcare properties. Its portfolio includes senior housing, outpatient medical facilities, and other health-related real estate.
Read more on WELL →